Fabtech Technologies Limited — Q4 FY26 earnings call

Call held 28 Apr 2026

Management summary

Fabtech Technologies Limited delivered a strong Q4 and FY26 performance, with significant growth in total income and EBITDA, driven by strategic transformation and global expansion. The company's balance sheet was strengthened by an equity infusion and debt reduction. While geopolitical challenges impacted margins and receivables increased, management is focused on operational discipline and projects continued growth and margin improvement for FY27, supported by a robust order book.

Highlights

  • Total income for FY26 grew by 28.4% year on year to 431.33 crore, demonstrating strong top-line growth.

  • EBITDA increased by 18.29% to 55.56 crores for FY26, reflecting operational efficiency.

  • Operational PAT for FY26 increased by 17.4% to 36.6 crores, indicating core business profitability.

  • Cash and bank balance rose sharply to 208.57 crore, and total equity expanded to 419.77 crore, strengthening the financial position.

  • Order book stands at over 900 crores as of March 31, 2026, providing strong revenue visibility for the next 18-24 months.

Concerns

  • Receivables have risen to 204.34 crore, making receivable management a strategic operational priority.

  • Margins were impacted by increased execution costs, higher RMC, and global geopolitical disruptions, despite revenue growth.

  • The company faced challenges in deploying 50 crores of working capital due to monitoring agency restrictions, now being addressed.

Key financials

3 periods

Headline

  • Cash and Bank Balance
    ₹208.57 Cr
  • Total Equity
    ₹419.77 Cr
  • Receivables
    ₹204.34 Cr

Q4 FY26

  • Total Income
    ₹168.24 Cr
    YoY +22%
  • Net Profit
    ₹22.06 Cr

FY26

  • Total Income
    ₹431.33 Cr
    YoY +28.4%
  • EBITDA
    ₹55.56 Cr
    YoY +18.3%
  • Operational PAT
    ₹36.6 Cr
    YoY +17.4%
  • Total Net Profit
    ₹38.36 Cr
  • Other Income
    ₹21 Cr

What they filed

Q1 FY27: revenue up 10.2%, net profit up 168.7% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue59 104 135 68 121 +107%63 −40%159 +18%75 +10%
EBITDA5 23 18 -6 30 +564%-12 −151%22 +21%4 +168%
Net profit5 20 15 -6 28 +449%-6 −128%22 +46%4 +169%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Order book

high confidence

Total value

₹900 Cr

as of 2026-03-31 quantified

Execution

deliver in next 18 to 24 months

Composition

  • UAE (geography)
  • Saudi Arabia (geography)
  • Iraq (geography)
  • Kenya (geography)
  • Other parts of Africa (geography)
  • Northern Africa (Algeria, Morocco, Egypt, Ethiopia) (geography)

Pipeline

deal pipeline tcv

hot lead pipeline with offers in the market

Management highlighted strong revenue visibility from the order book and improved conversion rates from the hot lead pipeline.

Source: Prepared remarks

Capital allocation

high confidence
  • Capex Capex disclosed
    • Strategic equity infusion for long-term capacity for expansion ₹230 Cr
    • Increasing internal capability and making the internal stream extremely strong
    • Talent acquisition
    A key milestone this year was our strategic equity infusion of approximately ₹230 crores, which fundamentally reset our balance sheet and strengthen our long-term capacity for expansion. Our total equity expanded to 419.77 crore while cash and bank balance rose sharply to 208.57 crore, making this the strongest financial position in Fabtech history. This was not just capital risk, it was strategically capacity created for the future.
  • Debt Debt disclosed
    • Repayment Reduced debt from 54 crores to 42 crores ₹12 Cr
    We've reduced our debt from 54 crores to 42 crores. Current borrowing is from 54 crores to 42 crores.
  • M&A JBN acquisition in the West Acquisition · Pending regulatory

    Strategic expansion

    The due diligence process is ongoing with our JBN acquisition in the West that has been under discussion.
  • Liquidity Cash ₹208.57 Cr Strong liquidity position maintained despite focus on cash and collection.
    Our total equity expanded to 419.77 crore while cash and bank balance rose sharply to 208.57 crore, making this the strongest financial position in Fabtech history.

Guidance & targets

Revenue

  • Revenue Growth Revenue · FY27 · High confidence approximately 25%
    Based on current momentum, we are projecting approximately 25% growth ahead, alongside an improvement in PAT margin towards 9.9% to 10.5% range.

    — Ashwani Singh

Profitability

  • PAT Margin Profitability · FY27 · High confidence 9.9% to 10.5%
    Based on current momentum, we are projecting approximately 25% growth ahead, alongside an improvement in PAT margin towards 9.9% to 10.5% range.

    — Ashwani Singh

  • EBITDA Margin Profitability · Implied FY27 · High confidence 13 to 14%
    at EBITDA level, our target is to do around 13 to 14%

    — Karan Doshi

  • PAT Margin Profitability · Implied FY27 · High confidence 9 to 11%
    PAT level will be between 9 to 11% is what our internal targets are.

    — Karan Doshi

  • PAT Guidance Profitability · FY28 · High confidence 12 to 14%
    Are you on track for your FY28 PAT guidance of 12 to 14% given we have just shrunk in this current year? Thank you. Aman Anavkar: We're on track, I would say.

    — Aman Anavkar

Order Book

  • Order Book Growth (conversion/inflow) Order Book · This year (FY27) · Medium confidence 25 to 30%
    We expect to grow with around 25 to 30%, as mentioned by the CEO.

    — Karan Doshi

Margin

  • RMC as a percentage of sales Margin · Implied FY27 · High confidence 44 to 46 percent
    So RMC as a percentage of sales would be between 44 to 46 percent if you look at the material cost.

    — Karan Doshi

  • Contribution Margin Margin · Implied FY27 · High confidence around 45 percent
    The contribution margin will be between around 45 percent is what we target.

    — Karan Doshi

What to watch in Q1 FY27

PAT Margin Improvement

FY27
Current 8.48% (36.6 crores / 431.33 crores for FY26)
Target 9.9% to 10.5% range

Why it matters

This is a key profitability target for FY27, indicating the effectiveness of operational discipline and cost efficiencies.

Based on current momentum, we are projecting approximately 25% growth ahead, alongside an improvement in PAT margin towards 9.9% to 10.5% range.

Risks & concerns

  • Geopolitical Disruptions and Supply Chain Volatility

    high

    Global geopolitical tensions, regional conflicts, and supply chain disruptions impacted freight economics and execution costs, particularly in Q4 FY26.

    Management acknowledged

  • High Receivables

    medium

    Receivables have risen to 204.34 crore, making collection a strategic operational priority to ensure healthy working capital cycle.

    Management acknowledged

  • Client-Side Civil Infrastructure Readiness Impacting Project Timelines

    medium

    Order conversion timelines are variable due to client-side civil infrastructure readiness, which impacts the company's execution schedule.

    Management acknowledged

  • Currency Devaluation in Emerging Markets

    low

    Operating in pharmaceutical emerging markets exposes the company to currency devaluation, mitigated by billing in USD.

    Management acknowledged

Q&A highlights

7 direct
Impact of Middle East War on Q1 Margins and Operations Direct
I would say firstly, in terms of balancing the order book, while we were exposed or concentrated in the Middle East as of last year, there is a lot of positive balance that has come in the order pipeline from Africa and other markets which have not been impacted with the war currently in the Middle East. With the scenario in the Middle East, be it Saudi Arabia, be it the projects ongoing in Iraq or in UAE, there has been a turbulent environment where our focus has been more on ensuring that we stand by our clients with the ongoing deliveries and installation commissioning ongoing.

Analysts probed on the impact of geopolitical tensions on current and future profitability, and management detailed mitigation strategies including diversification and localization.

Asked by Darshil Zaveri

Order Book Conversion Timelines and Announcement Policy Direct
So, something that we've learned throughout this journey of becoming public, Darshil, is that our investors want stable quarter to quarter understanding and growth in the market. Right? We have been reiterating that we are a very lumpy business, that our quarter four surpass all the quarters and that we are not a quarter-to-quarter story. QSQT, right? But we have realized that the order conversion timelines are more variable on the client side, dependent on civil infrastructure readiness. That is what impacts our side of the business. Now, the internal strategy has become, to control these timelines by controlling the pre-engineered building structures as well and bidding for these projects.

Analyst questioned the speed of converting the 200M USD pipeline and the company's policy on announcing new wins, leading to management explaining the lumpy nature of business and efforts to control timelines.

Asked by Darshil Zaveri

Passing on Price Increases due to Raw Material and Freight Costs Direct
Just as an example, if we are finalizing the projects in 2025 at X dollar or X INR and this increases by, let's say, 50 to 60%, then we have a variation clause where we sit down with our clients and we explain the entire situation to them. Now, obviously, all of our clients have been in business for decades. They themselves understand that while they are also importing materials, freight prices have gone up absurdly.

Analyst inquired about the company's ability to pass on increased costs, and management clarified the use of variation clauses and client understanding in long-term relationships.

Asked by Ankit Gupta

Geographic Split of the 900 Crore Order Book Partial
So just to qualitatively answer that, it is split between UAE, Saudi Arabia, Iraq, Kenya, other parts of Africa as well as Northern Africa, which is Algeria, Morocco, some parts of Egypt, some parts of Ethiopia. So, there is a split of the exposure across the region. While we will give you the exact numbers in a minute, I hope that answers the geography issue.

Analyst sought a quantitative breakdown of the order book by geography, but management provided a qualitative list of regions without specific numbers.

Asked by Ankit Gupta

Delay in Deploying IPO Funds Direct
Number one, I would not say delay, it's an active call. The due diligence process is ongoing with our JBN acquisition in the West that has been under discussion. There are mitigations that were taking place while we're bidding for projects in this region. The acquisition has yet not gone through because we want to be sure of where we're deploying the money. Number 2, the talent acquisition is ongoing, right?

Analyst questioned the delay in utilizing IPO funds, and management explained the strategic reasons behind the phased deployment, including M&A due diligence and talent acquisition.

Asked by Bhavika

RMC Percentage of Sales and Inventory Build-up Direct
So RMC as a percentage of sales would be between 44 to 46 percent if you look at the material cost. Sorry, contribution margin, around 55 percent. The contribution margin will be between around 45 percent is what we target. ... Just to personally answer your last question, we never build up inventory. That's why the lean model always helps in executing the project. It is based on JIT system, just in time manufacturing, and it is based on procurement as per design and engineering VOQs. So, we don't face a challenge in terms of inventory stocking. So, the margins don't shrink on that aspect.

Analyst asked about the RMC percentage and potential margin impact from inventory, to which management provided targets and clarified their JIT inventory model.

Asked by Aniket Madhavani

Domestic Business Order Book and Strategy Direct
India's side of the business, which is India focused cleanrooms, resides with Fabtech Technologies Cleanrooms Limited. So, we don't do projects in India personally as Fabtech Technologies Limited. So, I will not be able to address the order pipeline of FTCL. At the same time, I would love to say they're doing well. We know it, but we will not be able to address it right now. ... Just to one highlight when we talk about this one project, the reason that it has been undertaken as Fabtech Technologies Limited is because it is a vaccine product development facility in Mumbai. It's called GCMC. And that is helping us with a lot of international project referrals and influence. And it was a very strategic decision to execute this project in India.

Analyst inquired about the Indian order book, leading to clarification on the company's structure for domestic projects and the strategic rationale for a specific project in India.

Asked by Bhavika

FY27 Revenue and FY28 PAT Guidance Discrepancy Direct
You had given an FY27 revenue targets of like 530 to 600 crores, but right now you are seeing this 25% on the top line growth, so that is not, you know, matching the numbers you had given. And also, are you on track for your FY28 PAT guidance of 12 to 14% given we have just shrunk in this current year? ... Aman Anavkar: We're on track, I would say.

Analyst challenged the consistency of FY27 revenue guidance and sought confirmation on FY28 PAT targets, which management affirmed.

Asked by Rahil

2 min read 5 chapters

Detailed narrative

FY26 Performance and Strategic Transformation

Fabtech Technologies Limited reported a landmark FY26, not just for its financial numbers but for structural transformation aimed at future scale. Total income grew by 28.4% year-on-year to 431.33 crores, with EBITDA increasing by 18.29% to 55.56 crores. The company focused on building foundations across operational architecture, leadership, infrastructure, market expansion, and capital allocation, aligning for a multi-year growth cycle. This preparedness is expected to drive operating leverage and improve cost efficiency in the future.

Financial Strength and Capital Allocation

The company's financial position was significantly strengthened in FY26. A strategic equity infusion of approximately ₹230 crores reset the balance sheet, leading to total equity expanding to 419.77 crores. Cash and bank balance rose sharply to 208.57 crores, making it the strongest financial position in Fabtech's history. Debt was reduced from 54 crores to 42 crores, and the company achieved positive operating cash flow. IPO funds are being strategically deployed for internal capability, talent acquisition, and due diligence for a JBN acquisition in the West.

Global Expansion and Localization Strategy

Fabtech operates as an international brand across 60+ major geographies, with global business anchored by UAE and Saudi Arabia. The company's expansion in Kenya has shown strong momentum, reinforcing Africa as a powerful long-term corridor. Localization in regions like Saudi Arabia is viewed as a strategic necessity, driving trust, execution, capacity, and access. This strategy has enabled the company to secure multiple projects in the Middle East, North Africa, and other African regions, strengthening local pharmaceutical production capabilities.

Operational Discipline and Margin Management

Operational discipline has sharpened, with a focus on cash and collection, especially as receivables rose to 204.34 crores. Despite global macroeconomic pressures, including geopolitical disruptions and supply chain challenges, the company maintained client commitments. While margins were impacted by increased execution costs (up 43%) and RMC (up 33%), management uses variation clauses in contracts and a relationship-based approach to mitigate these impacts, billing in USD to offset currency risks.

Order Book and Future Outlook

The company's order book stands strong at over 900 crores as of March 31, 2026, providing revenue visibility for 18-24 months. A 'hot lead' pipeline of approximately 200 million USD is currently being pursued, with order conversion rates improving from 11% to a target of 16-17%. For FY27, management projects approximately 25% revenue growth and an improvement in PAT margin to a range of 9.9% to 10.5%. The company is also on track for its FY28 PAT guidance of 12% to 14%.

This is an AI-generated summary of a publicly available earnings call transcript.